Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.729
+0.029 (1.06%)
Apr 25, 2025, 12:19 PM EDT - Market open

Anixa Biosciences Market Cap

Anixa Biosciences has a market cap or net worth of $87.84 million as of April 25, 2025. Its market cap has decreased by -15.29% in one year.

Market Cap
87.84M
Enterprise Value
69.90M
1-Year Change
-15.29%
Ranking
Category
Stock Price
$2.73

Market Cap Chart

Since December 1, 1998, Anixa Biosciences's market cap has increased from $83.20M to $87.84M, an increase of 5.58%. That is a compound annual growth rate of 0.21%.

History

DateMarket Cap% Change
Apr 24, 202586.90M16.33%
Dec 31, 202474.70M-38.06%
Dec 29, 2023120.60M-7.44%
Dec 30, 2022130.30M46.40%
Dec 31, 202189.00M21.92%
Dec 31, 202073.00M10.11%
Dec 31, 201966.30M-10.04%
Dec 31, 201873.70M106.44%
Dec 29, 201735.70M-24.52%
Dec 30, 201647.30M79.85%
Dec 31, 201526.30M10.04%
Dec 31, 201423.90M-39.34%
Dec 31, 201339.40M18.32%
Dec 31, 201233.30M73.44%
Dec 30, 201119.20M-39.81%
Dec 31, 201031.90M-65.14%
Dec 31, 200991.50M61.95%
Dec 31, 200856.50M-63.00%
Dec 31, 2007152.70M62.27%
Dec 29, 200694.10M31.24%
Dec 30, 200571.70M-0.42%
Dec 31, 200472.00M94.07%
Dec 31, 200337.10M183.21%
Dec 31, 200213.10M-52.88%
Dec 31, 200127.80M-35.94%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 735.92B
UnitedHealth Group 388.88B
Johnson & Johnson 380.51B
AbbVie 306.62B
Novo Nordisk 284.50B
Abbott Laboratories 227.73B
Novartis AG 209.93B
AstraZeneca 208.11B
Market Cap Rankings